GDC-0941, also known as Pictilisib, is a highly potent and selective class I PI3K kinase inhibitor. Its IC50 values for for PI3K p110 α, β, δ and γ isoforms are 3nM, 33nM, 3nM, 75nM, and for DNA-PK and mTOR are 1230nM and 580nM. It has been in multiple phase I/II clinical trials targeting several advanced or metastatic solid tumors.

GDC-0941, also known as Pictilisib, is a highly potent and selective class I PI3K kinase inhibitor. Its IC50 values for for PI3K p110 α, β, δ and γ isoforms are 3nM, 33nM, 3nM, 75nM, and for DNA-PK and mTOR are 1230nM and 580nM. It has been in multiple phase I/II clinical trials targeting several advanced or metastatic solid tumors.